pharmaceutical investing Alimera Sciences and Knight Therapeutics Announce Filing of New Drug Submission for Iluvien® in Canada
Horizon Pharma plc Announces the U.S. Patent and Trademark Office Issuance of an Additional Notice of Allowance With Claims Covering RAYOS® (prednisone) Delayed-Release Tablets
Q BioMed Inc. Advisor and Mannin Research Inc CSO Dr Susan Quaggin Discusses Glaucoma and Man-01 with Eye on Vision Radio
EyeGate Announces Encouraging Interim Data from Phase 1b/2a Clinical Trial of EGP-437 for Treatment of Ocular Inflammation and Pain Post Cataract Surgery
SAGA Metals Reports Assays from R-0044 to R-0046 with Intercepts Including 58.33% Fe2O3, 8.78% TiO2, 0.415% V2O5 from 2026 Drilling at Trapper South, Radar Critical Minerals Project in Labrador
Nuvau Expands Its Exploration Program Targeting Key Base Metal and Never-Before-Drilled Gold Targets in the Matagami District
